Clinical and Preclinical Quality Director

Clinical and Preclinical Quality Director

Summary The Clinical and Preclinical Quality Director (CQD) will lead the development, implementation, and communication of high-quality standards to ensure the delivery of global clinical studies. With a focus on proactive quality management, this role supports Clinical Development by driving quality excellence, safeguarding data integrity, and enabling R&D objectives for the submission of new therapies. The CQD plays a key role in ensuring adherence to the Quality System and execution of RDQA Quality System Excellence, including CAPA, Change Management, Quality Risk Management, and Documentation Standards.

As the primary CQA contact for regulatory GCP inspections, the CQD will lead inspection readiness and execution, while supporting a broad range of GxP inspections across sponsors and sites. This role provides expert technical quality guidance and consultation to R&D colleagues and Development Operations business partners.

This position reports directly to the Head of Quality at ARTBIO.

Main Duties and Responsibilities

• Ensure a continuous state of compliance with global and local regulations, ARTBIO policies, and procedures driving inspection readiness for clinical trials and investigations inspections to deliver strong business outcomes while positioning ARTBIO for future success.
• Develop and implement innovative quality strategies for clinical and preclinical programs by collaborating with cross-functional stakeholders. Provide timely and effective responses to compliance issues, audits, and inspections impacting development operations, and lead reportability decisions for serious breaches across countries.
• Develop and lead initiatives to proactively assess quality risks in clinical and preclinical activities, including data integrity issues, and drive risk identification, mitigation, and prevention. Facilitate key quality improvements and innovation while promoting a culture of continuous regulatory preparedness.
• Advises study teams on procedural frameworks, including global clinical processes, procedural documents, and applicable Quality & Compliance manual documents, in line with international guidelines, such as ICH-GCP, industry standards, and local regulations.
• Provides expert guidance on clinical trial regulations, monitors regulatory changes, and ensures local teams and processes remain current and compliant.
• Plan and conduct quality control activities in line with the annual quality plan, including performing accompanied site visits. Performs any required QC visits / QC activities.
• Regularly reviews protocol deviations and ensures timely reporting of quality issues to local Authorities and in ARTBIOs internal systems, in accordance with QMS processes.
• Shares learnings from audits and inspections with staff and across Clinical and Quality networks, and communicates global and regional insights to local teams.
• Serves as a key contact in the evaluation and management of fraud / poor quality cases, and communicates with Quality Assurance (QA), and management, as required.
• Actively leads the conduct of GCP / Clinical investigations of inspections, providing expert guidance in strategy and support to enable successful inspections and high-quality CAPAs.
• Supports the implementation of general QA, clinical, and preclinical global procedures and systems by providing review input and QA approval of global procedural documents by request.

Qualifications & Experience Required

About Us ARTBIO is re-defining cancer care by developing a new class of radioligand therapies (RLT) which harness the power of 212Pb and deliver it directly to the tumour. Targeted RLT is one of the fastest growing areas of oncology research and investment. The foundational technology, termed AlphaDirect, was born out of elegant research by our scientific founders, Roy Larsen and yvind Bruland, inventors of XofigoTM. ARTBIO is leveraging this groundbreaking science and expediting novel drug discovery targets which broadly exploit the unmet medical need and opportunity in revolutionising cancer care. Supported by a committed group of investors, ARTBIO has built a highly experienced, multi-disciplinary team of drug-hunters and developers. For more information on our strategy and emerging pipeline, please visit www.artbio.com and follow-us on . As an emerging, global biotech with locations in Cambridge, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.

EEO Statement ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or veteran status. If you have a disability or special need that requires accommodation, please let us know.

ARTBIO does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between ARTBIO and the agency. ARTBIO will not pay any fees related to unsolicited resumes.

PI2e5d66933dda-30511-39134410